Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules-Reference-Cited by-同舟云学术

Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules

Published:2019-02-11 Issue:1 Volume:4 Page:
ISSN:2059-0105
Container-title:npj Vaccines
language:en
Short-container-title:npj Vaccines

Author:

Andersen Tor Kristian,Huszthy Peter C.,Gopalakrishnan Ramakrishna P.,Jacobsen Johanne T.,Fauskanger Marte,Tveita Anders A.,Grødeland Gunnveig,Bogen Bjarne

Funder

KG Jebsen Foundation

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology,Immunology

Link

http://www.nature.com/articles/s41541-019-0101-0.pdf

Reference51 articles.

1. Lambert, P. H., Liu, M. & Siegrist, C. A. Can successful vaccines teach us how to induce efficient protective immune responses? Nat. Med. 11, S54–S62 (2005).

2. Garside, P. et al. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 281, 96–99 (1998).

3. Victora, G. D. & Nussenzweig, M. C. Germinal centers. Annu. Rev. Immunol. 30, 429–457 (2012).

4. Phan, T. G. et al. High affinity germinal center B cells are actively selected into the plasma cell compartment. J. Exp. Med. 203, 2419–2424 (2006).

5. Fossum, E. et al. Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8 + T-cell responses against influenza virus. Eur. J. Immunol. 45, 624–635 (2015).

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crimean Congo hemorrhagic fever virus nucleoprotein and GP38 subunit vaccine combination prevents morbidity in mice;npj Vaccines;2024-08-14

2. Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins;Nature Communications;2024-02-12

3. A novel SARS-CoV-2 Beta RBD DNA vaccine directly targeted to antigen-presenting cells induces strong humoral and T cell responses;Scientific Reports;2023-11-02

4. PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity;Journal for ImmunoTherapy of Cancer;2023-10

5. Glucose oxidation-dependent survival of activated B cells provides a putative novel therapeutic target for lupus treatment;iScience;2023-09